REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
13/06/2026
Voltar para busca
Dado oficial do USPTO
SGD
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
55
Atualização mais recente
14/06/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 40
Data de depósito
02/06/2016
Data de registro
13/06/2017
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
11/09/2024
Última transação
14/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
708
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
25
Localização do titular
Zofingen, CH
Examinador
WHITTAKER BROWN, TRACY
Localização atual
FILE DESTROYED
Titulares e representantes
Titulares
Siegfried Holding AG
Representantes
Jeffrey H. Handelsman GREENBLUM & BERNSTEIN, P.L.C.
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 40
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical preparations for use in industryscience and photographyas well as in agriculturehorticulture and forestry; unprocessed artificial resinsunprocessed plastics; fertilizing preparations; fire-extinguishing compositions; tempering preparations for use in and soldering ; chemical substances for preserving foodstuffs ; tanning agents for use in the manufacture of leatheroils for tanning leather; adhesives for use in industry; alkaloids for industrial purposes; Methyl and Acetic acid esters; acids
Classe 5
Pharmaceuticalmedical and veterinary preparations for treatment of benign prostate hyperplasiadepressionchronic myeloid leukaemiaglaucomaocular hypertensionhypertensionhypotensionasthmaschizophreniabipolar disorderdiabetesmental illnessmigrainescough and coldblood clotsaddictionskin disorderscentral nervous system diseasesurinary tract infection; Dietetic substances and foodstuffs for medical and veterinary useantidepressant for companion animalslice treatment; Disinfectantspreparations for destroying vermin; Fungicidesherbicides; Alkaloids for medical use; Analgesics; General anesthetics; Chemical preparations for medical use ; Chemical preparations for pharmaceutical use for treatment of benign prostate hyperplasiadepressionchronic myeloid leukaemiaglaucomaocular hypertensionhypertensionhypotensionasthmaschizophreniabipolar disorderdiabetesmental illnessmigrainescough and coldformation of blood clotsaddictionskin disorderscentral nervous system diseasesurinary tract infection; Chemical preparations for veterinary usefor antidepressant for companion animalslice treatment; Cellulose esters for pharmaceutical use; Hormones for medical use; Potassium salts for medical usemedicated bath salts; Preparations for acne treatments; Controlled substancesprescription narcotics; Opiates; Pharmaceutical preparationsfor treatment of benign prostate hyperplasiadepressionchronic myeloid leukaemiaglaucomaocular hypertensionhypertensionhypotensionasthmaschizophreniabipolar disorderdiabetesmental illnessmigrainescough and coldformation of blood clotsaddictionskin disorderscentral nervous system diseasesurinary tract infection; Medicinesulfonamides; Veterinary preparations for treatment of depression for companion animalslice treatment; Salts for medical use for treatment of benign prostate hyperplasiadepressionchronic myeloid leukaemiaglaucomaocular hypertensionhypertensionhypotensionasthmaschizophreniabipolar disorderdiabetesmental illnessmigrainescough and coldformation of blood clotsaddictionskin disorderscentral nervous system diseasesurinary tract infection; Pharmaceutical alcoholsmedicinal alcohols; Medicines for human medicine for treatment of benign prostate hyperplasiadepressionchronic myeloid leukaemiaglaucomaocular hypertensionhypertensionhypotensionasthmaschizophreniabipolar disorderdiabetesmental illnessmigrainescough and coldformation of blood clotsaddictionskin disorderscentral nervous system diseasesurinary tract infection; Medicines for veterinary use for treatment of depression for companion animalslice treatment; Medicines for dental use for local anesthetics; Chemical-pharmaceutical preparations for injections for treatment of benign prostate hyperplasiadepressionchronic myeloid leukaemiaglaucomaocular hypertensionhypertensionhypotensionasthmaschizophreniabipolar disorderdiabetesmental illnessmigrainescough and coldformation of blood clotsaddictionskin disorderscentral nervous system diseasesurinary tract infection; Chemical preparations for medical or veterinary use for treatment of benign prostate hyperplasiadepressionchronic myeloid leukaemiaglaucomaocular hypertensionhypertensionhypotensionasthmaschizophreniabipolar disorderdiabetesmental illnessmigrainescough and coldformation of blood clotsaddictionskin disorderscentral nervous system diseasesurinary tract infectiontreatment of depression for companion animalslice treatment and veterinary preparations for treatment of benign prostate hyperplasiadepressionchronic myeloid leukaemiaglaucomaocular hypertensionhypertensionhypotensionasthmaschizophreniabipolar disorderdiabetesmental illnessmigrainescough and coldblood clotsaddictionskin disorderscentral nervous system diseasesurinary tract infection; Dietetic substances and foodstuffs for medical and veterinary useantidepressant for companion animalslice treatment; Disinfectantspreparations for destroying vermin; Fungicidesherbicides; Alkaloids for medical use; Analgesics; General anesthetics; Chemical preparations for medical use; Chemical preparations for pharmaceutical use for treatment of benign prostate hyperplasiadepressionchronic myeloid leukaemiaglaucomaocular hypertensionhypertensionhypotensionasthmaschizophreniabipolar disorderdiabetesmental illnessmigrainescough and coldformation of blood clotsaddictionskin disorderscentral nervous system diseasesurinary tract infection; Chemical preparations for veterinary usefor antidepressant for companion animalslice treatment; Cellulose esters for pharmaceutical use; Hormones for medical use; Potassium salts for medical usemedicated bath salts; Preparations for acne treatments; Controlled substancesprescription narcotics; Opiates; Pharmaceutical preparationsfor treatment of benign prostate hyperplasiadepressionchronic myeloid leukaemiaglaucomaocular hypertensionhypertensionhypotensionasthmaschizophreniabipolar disorderdiabetesmental illnessmigrainescough and coldformation of blood clotsaddictionskin disorderscentral nervous system diseasesurinary tract infection; Medicinesulfonamides; Veterinary preparations for treatment of depression for companion animalslice treatment; Salts for medical use for treatment of benign prostate hyperplasiadepressionchronic myeloid leukaemiaglaucomaocular hypertensionhypertensionhypotensionasthmaschizophreniabipolar disorderdiabetesmental illnessmigrainescough and coldformation of blood clotsaddictionskin disorderscentral nervous system diseasesurinary tract infection; Pharmaceutical alcoholsmedicinal alcohols; Medicines for human medicines for treatment of benign prostate hyperplasiadepressionchronic myeloid leukaemiaglaucomaocular hypertensionhypertensionhypotensionasthmaschizophreniabipolar disorderdiabetesmental illnessmigrainescough and coldformation of blood clotsaddictionskin disorderscentral nervous system diseasesurinary tract infection; Medicines for veterinary use for treatment of depression for companion animalslice treatment; Medicines for dental use for local anesthetics; Chemical-pharmaceutical preparations for injectionstreatment of benign prostate hyperplasiadepressionchronic myeloid leukaemiaglaucomaocular hypertensionhypertensionhypotensionasthmaschizophreniabipolar disorderdiabetesmental illnessmigrainescough and coldformation of blood clotsaddictionskin disorderscentral nervous system diseasesurinary tract infection; Chemical preparations for medical or veterinary use for treatment of benign prostate hyperplasiadepressionchronic myeloid leukaemiaglaucomaocular hypertensionhypertensionhypotensionasthmaschizophreniabipolar disorderdiabetesmental illnessmigrainescough and coldformation of blood clotsaddictionskin disorderscentral nervous system diseasesurinary tract infectiontreatment of depression for companion animalslice treatment
Classe 40
Treatment of materials in the nature of spry dryingmillingmicronisationnitrationhydrogenationphosgenationhalogenationoxidationreduction; Custom manufacture of pharmaceutical products per customer order and in accordance with customer requirements; custom manufacture of pharmaceutical products as per customer order and in accordance with customer requirementsacetalaldehydsalkaloidsestersketonesmercaptanoxalatesacidsvitamins and ingredients used in the manufacture of medicines against cancer
Publicações
Histórico de despachos e eventos da marca no USPTO.
55 publicações encontradas
RNWL
INTERNATIONAL REGISTRATION RENEWED
12/03/2026
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
27/09/2025
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
02/09/2025
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
01/09/2025
INPC
INVALIDATION PROCESSED
01/09/2025
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
12/05/2025
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
11/09/2024
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
11/09/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/04/2024
ES75
TEAS SECTION 71 & 15 RECEIVED
03/08/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
23/06/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/11/2022
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
13/06/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
30/07/2020
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
08/05/2019
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
17/04/2019
A7OK
AMENDMENT UNDER SECTION 7 - PROCESSED
17/08/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/07/2018
ES7R
TEAS SECTION 7 REQUEST RECEIVED
19/06/2018
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
28/10/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
18/09/2017
FIMP
FINAL DISPOSITION PROCESSED
18/09/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
13/09/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
13/06/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28/03/2017
PUBO
PUBLISHED FOR OPPOSITION
28/03/2017
GPNX
NOTIFICATION PROCESSED BY IB
25/03/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/03/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/03/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/03/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
21/02/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/02/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
07/02/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/02/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
07/02/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/02/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
26/01/2017
GNRT
NON-FINAL ACTION E-MAILED
26/01/2017
CNRT
NON-FINAL ACTION WRITTEN
26/01/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/12/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/12/2016
ALIE
ASSIGNED TO LIE
08/12/2016
RFNT
REFUSAL PROCESSED BY IB
25/11/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
22/11/2016
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
22/11/2016
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
22/11/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/11/2016
RFRR
REFUSAL PROCESSED BY MPU
09/11/2016
MAFR
APPLICATION FILING RECEIPT MAILED
18/10/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
15/10/2016
CNRT
NON-FINAL ACTION WRITTEN
14/10/2016
DOCK
ASSIGNED TO EXAMINER
12/10/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/10/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/10/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SGD ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.